Literature DB >> 22281946

[A young patient with paraganglioma syndrome type I. An interdisciplinary challenge].

C Brase1, H Neumann, M Lell, S Schwarz-Furlan, K Rogler, J Hornung.   

Abstract

A 33-year old patient presented at our outpatient department with pulse-synchronous tinnitus in the left ear of several years' standing. Examination of the left ear showed a neoplasm at the base of the meatus in front of the ear drum. In addition, there was paresis of the right hypoglossal nerve and right vocal cord. CT scan showed multiple paraganglioma in the head and neck region. Molecular genetic screening analysis showed a mutation of the SDHD gene and thus the diagnosis of paraganglioma syndrome type 1 was made. In the treatment concept presented here the main goal was preservation of function of the left cranial nerves due to the functional loss of the right cranial nerves X and XII. This goal could be achieved by means of a staged procedure in collaboration with radiotherapists.

Entities:  

Mesh:

Year:  2012        PMID: 22281946     DOI: 10.1007/s00106-011-2407-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  23 in total

Review 1.  [Paragangliomas in the head-/neck region. I: Classification and diagnosis].

Authors:  J Schipper; C C Boedeker; W Maier; H P H Neumann
Journal:  HNO       Date:  2004-06       Impact factor: 1.284

2.  Maternal transmission of symptomatic disease with SDHD mutation: fact or fiction?

Authors:  Hartmut P H Neumann; Zoran Erlic
Journal:  J Clin Endocrinol Metab       Date:  2008-05       Impact factor: 5.958

3.  Surgical management of carotid body tumors.

Authors:  S J Wang; M B Wang; T M Barauskas; T C Calcaterra
Journal:  Otolaryngol Head Neck Surg       Date:  2000-09       Impact factor: 3.497

Review 4.  [Paragangliomas and paraganglioma syndromes].

Authors:  C C Boedeker
Journal:  Laryngorhinootologie       Date:  2011-04-26       Impact factor: 1.057

5.  Staged Gamma Knife radiosurgery after tailored surgical resection: a novel treatment paradigm for glomus jugulare tumors.

Authors:  Jonathan P Miller; Maroun Semaan; Douglas Einstein; Cliff A Megerian; Robert J Maciunas
Journal:  Stereotact Funct Neurosurg       Date:  2009-01-28       Impact factor: 1.875

6.  Jugular foramen tumors: clinical characteristics and treatment outcomes.

Authors:  Jose N Fayad; Bahar Keles; Derald E Brackmann
Journal:  Otol Neurotol       Date:  2010-02       Impact factor: 2.311

7.  SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.

Authors:  Jean-Pierre Bayley; Henricus P M Kunst; Alberto Cascon; Maria Lourdes Sampietro; José Gaal; Esther Korpershoek; Adolfo Hinojar-Gutierrez; Henri J L M Timmers; Lies H Hoefsloot; Mario A Hermsen; Carlos Suárez; A Karim Hussain; Annette H J T Vriends; Frederik J Hes; Jeroen C Jansen; Carli M Tops; Eleonora P Corssmit; Peter de Knijff; Jacques W M Lenders; Cor W R J Cremers; Peter Devilee; Winand N M Dinjens; Ronald R de Krijger; Mercedes Robledo
Journal:  Lancet Oncol       Date:  2010-01-11       Impact factor: 41.316

8.  SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.

Authors:  Huai-Xiang Hao; Oleh Khalimonchuk; Margit Schraders; Noah Dephoure; Jean-Pierre Bayley; Henricus Kunst; Peter Devilee; Cor W R J Cremers; Joshua D Schiffman; Brandon G Bentz; Steven P Gygi; Dennis R Winge; Hannie Kremer; Jared Rutter
Journal:  Science       Date:  2009-07-23       Impact factor: 47.728

Review 9.  Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.

Authors:  B Havekes; E W Lai; E P M Corssmit; J A Romijn; H J L M Timmers; K Pacak
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-12       Impact factor: 2.346

Review 10.  Surgical management of jugular foramen meningiomas: a series of 13 cases and review of the literature.

Authors:  Mario Sanna; Andrea Bacciu; Maurizio Falcioni; Abdelkader Taibah; Paolo Piazza
Journal:  Laryngoscope       Date:  2007-10       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.